Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®

This trial is studying a new radiation treatment approach combined with a chemotherapy drug (vinorelbine/Navelbine) for patients with locally advanced non-small cell lung cancer (NSCLC) that cannot be removed with surgery. **You may be eligible if...** - You have been confirmed by biopsy to have locally advanced non-small cell lung cancer (stage IIB to IIIB) - Your general health score (ECOG) is 0 or 1 (fully active or able to carry out light work) - You are able to follow the treatment and study schedule - Women must have a negative pregnancy test - A standard radiation plan meeting safety requirements is available for you **You may NOT be eligible if...** - You have an unstable medical condition (such as severe infection, heart disease, or serious liver or kidney problems) - You need supplemental oxygen through the nose - You have previously had chest radiation - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.